Earn Up to 2 Hours of CME!

DoubleTree by Hilton, San Juan P.R.

Pre-Registration is Required

Free of Charge

Program Description

The program will address strategies to reduce diagnostic delays by improving recognition of PsA signs and symptoms. Attendees will also review the latest evidence on the safety and efficacy of novel therapies, including PDE4 and TNF inhibitors, and learn how to apply clinical trial data to real-world treatment decisions.

In addition, the program will cover approaches for personalizing treatment plans and sequencing therapies to meet the individual needs of patients. Participants will examine the prevalence and management of comorbid conditions in those with moderate to severe psoriasis and psoriatic arthritis, explore both current and emerging therapeutic options, and develop effective treat-to-target strategies. The sessions will help clinicians recognize when to refer patients with psoriasis for rheumatologic evaluation, ensuring timely diagnosis and optimal management of PsA. Overall, this CME aims to provide actionable insights and practical tools for improving outcomes in patients with moderate to severe psoriasis and psoriatic arthritis.